Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Glimepiride (3mg) Tablet
Dosage Form : Tablet
Packaging Type : Blister
Packaging : 10*10
Price : ₹0/-
Glibclay 3 Tablet contains Glimepiride 3mg, a potent sulfonylurea used to improve glycemic control in patients with type-2 diabetes mellitus. It is effective in stimulating pancreatic insulin secretion and maintaining blood sugar levels within target ranges.
Glimepiride works by enhancing endogenous insulin release in response to elevated blood glucose, helping regulate both fasting and postprandial blood sugar levels. Its oral administration and once-daily dosing support patient adherence in long-term therapy.
This medicine is ideal for patients inadequately controlled on diet and exercise alone, offering reliable efficacy and a favorable safety profile. Its clinical use spans outpatient and hospital-based diabetes management programs.
Adding Glibclay 3 Tablet to your diabetes and metabolic-care portfolio strengthens your product offerings, creating strong opportunities in retail pharmacies, hospital supply, institutional distribution, export markets, and third-party manufacturing. Its high prescription rate ensures consistent demand and commercial viability.
Some patients may experience hypoglycemia, dizziness, nausea, or mild gastrointestinal discomfort. Rarely, allergic reactions, weight gain, or hematologic abnormalities may occur.
Glibclay 3 Tablet is indicated for the management of type 2 diabetes mellitus in patients whose blood sugar levels are not adequately controlled by diet and exercise alone. It helps improve glycemic control and reduce fasting and postprandial blood glucose levels.
Use strictly under medical supervision. Regular monitoring of blood glucose is recommended to prevent hypoglycemia. Avoid use in patients with severe renal or hepatic impairment. Follow the prescribed dosage and lifestyle modifications carefully.
Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.
Composition : Calcium Dobesilate Monohydrate I.P. 500 mg Capsule
Composition : L-Arginine (3gm) + Proanthocyanidin (75mg) sachet
Composition : Aminacrine HCl 0.1g + Cetrimide Cream 0.5g
Composition : Chlorhexidine Gluconate (0.20% w/w) + Silver Nitrate (0.20% w/w) cream
Composition : Hydroquinone (2% w/w) + Mometasone (0.1% w/w) + Tretinoin (0.025% w/w)
Composition : Fusidic Acid I.P. 2.00% w/w + Beclomethasone Dipropionate I.P. 0.025% w/w
Composition : Cranberry Extract 300mg + D-Mannose 600mg Tablet
Composition : Ketoconazole IP -2.0% w/w + Clobestasol Propionate IP 0.05% +Neomycin Sulphate eq to Neomycin 0.10% w/w + Tolnaflate IP 1.0% w/w + Iodochlorhydroxy Quinoline IP 1.0% w/w Cream base
Composition : Terbinafine (1% w/w)
Composition : Tretinoin 0.05% Cream